Načítá se...
NOVEL THERAPIES FOR FSGS: PRECLINICAL AND CLINICAL STUDIES
Focal segmental glomerulosclerosis (FSGS) is a rare but important cause of end stage kidney disease in children and adults. Current therapy, consisting of corticosteroids and calcineurin inhibitors, fails to achieve a sustained remission in the majority of patients. Therefore there is a pressing nee...
Uloženo v:
| Vydáno v: | Adv Chronic Kidney Dis |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409581/ https://ncbi.nlm.nih.gov/pubmed/25704355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ackd.2014.10.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|